Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

Stock analysts at StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued to investors on Friday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Stock Up 1.0 %

Shares of NYSE:RVP opened at $0.64 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. Retractable Technologies has a 52-week low of $0.56 and a 52-week high of $1.34. The business’s 50 day simple moving average is $0.69 and its two-hundred day simple moving average is $0.90. The firm has a market cap of $19.04 million, a P/E ratio of -1.18 and a beta of 1.98.

Insider Activity at Retractable Technologies

In related news, CEO Thomas J. Shaw acquired 71,422 shares of the stock in a transaction dated Friday, September 20th. The stock was purchased at an average cost of $0.82 per share, with a total value of $58,566.04. Following the completion of the purchase, the chief executive officer now directly owns 14,743,907 shares in the company, valued at $12,090,003.74. This trade represents a 0.49 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last 90 days, insiders acquired 176,995 shares of company stock valued at $132,936. 55.00% of the stock is owned by company insiders.

Institutional Investors Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC acquired a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies at the end of the most recent reporting period. Institutional investors and hedge funds own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.